1520 related articles for article (PubMed ID: 9074808)
1. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
2. Suicide inhibitors of cytochrome P450 1A1 and P450 2B1.
Hopkins NE; Foroozesh MK; Alworth WL
Biochem Pharmacol; 1992 Aug; 44(4):787-96. PubMed ID: 1510726
[TBL] [Abstract][Full Text] [Related]
3. A role for threonine 302 in the mechanism-based inactivation of P450 2B4 by 2-ethynylnaphthalene.
Roberts ES; Pernecky SJ; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1996 Jul; 331(2):170-6. PubMed ID: 8660695
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
5. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
Goosen TC; Mills DE; Hollenberg PF
J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
[TBL] [Abstract][Full Text] [Related]
6. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital.
He K; Falick AM; Chen B; Nilsson F; Correia MA
Chem Res Toxicol; 1996; 9(3):614-22. PubMed ID: 8728507
[TBL] [Abstract][Full Text] [Related]
7. Effects of bioflavonoids on hepatic P450 activities.
Obermeier MT; White RE; Yang CS
Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.
Roberts ES; Hopkins NE; Foroozesh M; Alworth WL; Halpert JR; Hollenberg PF
Drug Metab Dispos; 1997 Nov; 25(11):1242-8. PubMed ID: 9351899
[TBL] [Abstract][Full Text] [Related]
9. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta.
Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R
Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981
[TBL] [Abstract][Full Text] [Related]
10. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
Murray M; Butler AM; Stupans I
J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
[TBL] [Abstract][Full Text] [Related]
11. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.
Backes WL; Batie CJ; Cawley GF
Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863
[TBL] [Abstract][Full Text] [Related]
12. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.
Murray M; Butler AM
J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.
Chun YJ; Ryu SY; Jeong TC; Kim MY
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):389-93. PubMed ID: 11259321
[TBL] [Abstract][Full Text] [Related]
14. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
Yamazaki H; Shaw PM; Guengerich FP; Shimada T
Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine.
Dyck LE; Davis BA
Drug Metab Dispos; 2001 Aug; 29(8):1156-61. PubMed ID: 11454735
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne.
Roberts ES; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1998 Jun; 354(2):295-302. PubMed ID: 9637739
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.
Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF
Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
19. Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes.
Onderwater RC; Commandeur JN; Menge WM; Vermeulen NP
Chem Res Toxicol; 1999 May; 12(5):396-402. PubMed ID: 10328749
[TBL] [Abstract][Full Text] [Related]
20. Activation of amino-alpha-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes.
Shimada T; Guengerich FP
Cancer Res; 1991 Oct; 51(19):5284-91. PubMed ID: 1913651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
